Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
10/1996
10/23/1996CN1134113A Method for inducing antigen-specific T cell tolerance
10/23/1996CN1134109A Chemically-defined non-polymeric valency plateform molecules and conjugates thereof
10/23/1996CN1133839A Aroyl-piperidine derivatives
10/23/1996CN1033088C Process for preparing thiazolylbenzofuran derivs.
10/22/1996US5567684 Synthetic ganglioside derivatives
10/22/1996US5567683 Antiinflammatory agents
10/22/1996US5567594 Methods and compositions for the detection and treatment of diseases associated with antigens of microorganisms
10/22/1996US5567425 Plant extracts
10/17/1996WO1996032495A1 Monoclonal antibody specific for human 4-1bb and cell line producing same
10/17/1996WO1996032478A1 Altered polypeptides with increased half-life
10/17/1996WO1996032417A1 Antibodies against heart muscle actin
10/17/1996WO1996032386A1 Aryl glycinamide derivatives, methods of producing these substances and pharmaceutical compositions containing such compounds
10/17/1996WO1996032385A1 Novel substituted piperazine derivatives having tachykinin receptor antagonists activity
10/17/1996WO1996032383A1 Acetamide derivatives, process for producing the same, and medicinal composition containing the same
10/17/1996WO1996032381A1 Carbazole derivative
10/17/1996WO1996032380A1 Substituted indolylmethylene-oxindole analogues as tyrosine kinase inhibitors
10/17/1996WO1996032379A1 INDOLE DERIVATIVES AS cGMP-PDE INHIBITORS
10/17/1996WO1996032152A1 Pulmonary administration of dry powder alpha 1-antitrypsin
10/17/1996WO1996032149A1 Pulmonary delivery of aerosolized medicaments
10/17/1996WO1996032125A1 Methods for treating motor deficits
10/17/1996WO1996032122A1 Mistletoe extract and method
10/17/1996WO1996032119A1 Pharmaceutical compositions comprising synthetic peptide copolymer for prevention of gvhd
10/17/1996WO1996032111A1 Trapidil for use in the treatment of immuno-modulatorily influencible cases
10/17/1996WO1996032105A1 Lactacystin analogs
10/17/1996DE19514048A1 Trapidil zur Verwendung in der Therapie von immunmodulatorisch beeinflußbaren Krankheitsbildern Trapidil for use in the treatment of immunomodulatory influenced diseases
10/17/1996CA2368934A1 Metered dose inhaler for fluticasone propionate
10/17/1996CA2218208A1 Pulmonary administration of dry powder alpha 1-antitrypsin
10/17/1996CA2218033A1 Acetamide derivative, process for preparing the same, and a pharmaceutical composition containing the same
10/17/1996CA2217817A1 Lactacystin analogs
10/17/1996CA2217707A1 Indole derivatives as cgmp-pde inhibitors
10/17/1996CA2215389A1 Pharmaceutical compositions comprising synthetic peptide copolymer for prevention of gvhd
10/16/1996EP0737750A2 Expression of exogenous polynucleotide sequences in a vertebrate
10/16/1996EP0737250A1 Humanized antibodies and uses thereof
10/16/1996EP0737205A1 T-cell epitopes
10/16/1996EP0737197A1 Amino alkanoic esters of rapamycin
10/16/1996EP0737196A1 Diaryl 5,6-fused heterocyclic acids as leukotriene antagonists
10/16/1996EP0737195A1 New ginkgolide derivatives and a process for preparing them
10/16/1996EP0737194A1 Diazabicyclic neurokinin antagonists
10/16/1996EP0737076A1 Method for antigen-specific immunoregulation by t-cell alpha chain
10/16/1996EP0737068A1 2,3-diaryl-1-benzopyrans for treating dermatitis
10/16/1996EP0610179B1 Target specific antibody-superantigen conjugates and their preparation
10/16/1996EP0601062B1 Sirs vaccine and diagnosis method
10/16/1996EP0540673B1 Acetylene derivatives having lipoxygenase inhibitory activity
10/16/1996CN1133599A Recombinant IL4 antibodies useful in treatment of IL4 mediated disorders
10/16/1996CN1133563A Novel tripeptides useful in immune and CNS therapy
10/16/1996CN1133288A Compound with 1-(aryl Chain olefine)-4-(aryl methyl) piperazine structure, preparation process thereof and medicine thereof
10/16/1996CN1133189A Oral liquid for body building up
10/16/1996CN1033034C Method for preparation of crystalline interleukin-4
10/16/1996CN1033029C Prepn. of indenoindole compound
10/15/1996US5565560 Treating autoimmune diseases, preventing transplant rejection
10/15/1996US5565559 Culturing an fr-900506; protecting; salt formation; oxidation; reduction; deprotecting
10/15/1996US5565491 Use of phosphotyrosine phospatase inhibitors for controlling cellular proliferation
10/15/1996US5565463 9-subtituted-8-unsubstituted-9-deazaguanines
10/15/1996US5565448 Antiinflammatory agent, cardiovascular disorders, septic shock
10/15/1996US5565446 Useful in treatment of inflammatory diseases
10/15/1996US5565430 Azaaspartic acid analogs as interleukin-1β converting enzyme inhibitors
10/15/1996CA2067498C Composition for inducing granulocyte production or b cell production in peripheral blood
10/15/1996CA1338647C Inhibitors of lysyl oxidase
10/10/1996WO1996031617A1 Method of production of antigen-specific glycosylation inhibiting factor
10/10/1996WO1996031613A1 Expression library immunization
10/10/1996WO1996031607A2 Use of an 'immunodeficiency-virus suppressing lymphokine (isl)' to inhibit the replication of viruses, in particular of retroviruses
10/10/1996WO1996031604A1 Antibodies for the detection of hla-g
10/10/1996WO1996031527A1 Protease inhibiting succinic acid derivatives
10/10/1996WO1996031514A1 Ascomycins
10/10/1996WO1996031487A1 1,3-dihydro-2h-imidazol-2-one derivatives having pde iv and cytokinin inhibiting activity
10/10/1996WO1996031486A1 1,3-dihydro-1-(phenylalkenyl)-2h-imidazol-2-one derivatives having pde iv and cytokine inhibiting activity
10/10/1996WO1996031485A1 1,3-dihydro-1-(phenylalkyl)-2h-imidazol-2-one derivatives having pdeiv and cytokine activity
10/10/1996WO1996031236A1 Chlamydia vaccines
10/10/1996WO1996031224A1 Immunosuppressant
10/10/1996WO1996020215A3 Use of mhc-ii binding and/or mhc-ii mimicking molecules for the prevention and/or treatment of inflammatory diseases
10/10/1996WO1996012737A3 Compositions and treatment for multiple sclerosis
10/10/1996CA2217450A1 Use of an "immunodeficiency-virus suppressing lymphokine (isl)" to inhibit the replication of viruses, in particular of retroviruses
10/10/1996CA2217346A1 Method of production of antigen-specific glycosylation inhibiting factor
10/10/1996CA2216562A1 Ascomycins
10/10/1996CA2216092A1 Expression library immunization
10/10/1996CA2213620A1 Antibodies for the detection of hla-g
10/09/1996EP0736532A1 Pyrido(3,2-e)pyrazinones with antiasthmatic activity and process for their preparation
10/09/1996EP0736180A1 Methods and compositions for the detection and treatment of diseases associated with antigens of microorganisms
10/09/1996EP0736095A1 Human circulating cytokine cc-1
10/09/1996EP0736093A1 ANTISENSE NUCLEIC ACIDS FOR THE PREVENTION AND TREATMENT OF DISORDERS IN WHICH EXPRESSION OF c-erbB PLAYS A ROLE
10/09/1996EP0736036A1 Kininogen inhibitors
10/09/1996EP0736006A1 Phenylthiophenyl cycloalkenyl hydroxyureas as lipoxygenase inhibitors
10/09/1996EP0735898A1 Vaccines
10/09/1996EP0735897A1 "prophylaxis of allergic disease"
10/09/1996EP0735893A1 Alteration of immune response using pan dr-binding peptides
10/09/1996EP0735891A1 A 46 Kd HUMAN MILK FAT GLOBULE ANTIGEN
10/09/1996EP0735880A1 Use of vanadium molybdenum or tungsten complexes for controlling cellular proliferation
10/09/1996EP0735818A1 MACROPHAGE INFLAMMATORY PROTEINS-3, -4 AND -1 Sg(g)
10/09/1996EP0609415B1 Nitric esters of derivatives of the 2-(2,6-di-halophenylamino)phenylacetic acid and process for their preparation
10/09/1996CN1133064A GRB3-3 gene, variants and uses thereof
10/09/1996CN1133048A Oligopeptides derived from C-reactive protein fragments
10/09/1996CN1133047A Therapeutic peptide derivatives
10/09/1996CN1132640A Tonic wine with scorpion and ground beetle and its prepn process
10/09/1996CN1032951C Tortoise and soft-shelled turtle composition and its prep.
10/08/1996US5563162 Bradykinin antagonist quinolines
10/08/1996US5563151 Platelet activating factor receptor antagonists; antiinflammatory agents, analgesics
10/08/1996US5563145 Rapamycin 42-oximes and hydroxylamines
10/08/1996US5563144 Antiserotonins, their preparation and pharmaceutical compositions containing them
10/08/1996US5563143 Antiinflammatory agents, autoimmune disorders
10/08/1996US5563135 Immunosuppressive agent
1 ... 1045 1046 1047 1048 1049 1050 1051 1052 1053 1054 1055 1056 1057 1058 1059 1060 1061 1062 1063 1064 1065 ... 1172